3 Australian Businesses Tap Chainalysis to Monitor Risky Cryptocurrency Activity
Several Australian companies have turned to Chainalysis products in a bid to improve their regulatory compliance and reduce risks for users. Source
Read More
Risky
3 Reasons Why Oxford’s Record-Breaking COVID-19 Vaccine is a Risky Bet
AstraZeneca has announced that it will be distributing 400 million doses of Oxford University’s coronavirus vaccine from September. However, there are at least three reasons to suspect that the coronavirus vaccine may not work. No coronavirus vaccine has ever been produced, immunity may be short-lived, and it may actually
Read More